Dr House is an Emergency Department attending with a dual interest in medical education and ED operations and flow. She works with a team to improve throughput in teams of the ED and reduce patient wait times. She also is the director of the Emergency Medicine lecture series.
Dr. Fein conducts youth violence prevention research and has been the principal investigator (PI) or co-investigator of numerous federally funded projects addressing the youth violence epidemic through mixed-methods research, particularly community-based, participatory research (CBPR). He is currently the PI for a NICHD-funded study looking at the impact of a post-traumatic stress disorder (PTSD) prevention program on assault-injured youth and their families.
Dr. Connolly coordinates CHOP's participation in the electronic Medical Records and Genomics (eMERGE) Consortium, a major NHGRI-funded initiative to integrate health records and genomics. He also has led a range of neuropsychiatric studies and trained as neuropsychologist at Trinity College Dublin.
Dr. Pacifici's biomedical research spans three decades and has explored mechanisms of skeletal development and growth in fetal and postnatal life. Specifically, his focus has been on identifying the cellular and molecular mechanisms that regulate the differentiation of progenitor cells and permit assembly of distinct skeletal structures, and on aberrations of these mechanisms in pediatric skeletal disorders.
Dr. Weiss focuses on trainee assessment in the clinical learning environment, and on drivers of wellness and burnout in the workplace. She has a particular interest in understanding the intersection between trainee and educator identity and its impact on learners' personal and professional success.
Dr. Rempell is active in research evaluating the role of bedside ultrasound in the care of patients in the Emergency Department, as well as projects evaluating the efficacy of educational interventions to instruct attendings and residents about bedside ultrasound.
Dr. Ma focuses on immune engineering. He leverages genetic, chemistry, and engineering tools to dissect immune cell-cell and cell-tissue crosstalk and harness these crosstalk mechanisms to develop biomaterials, protein, and cell-based precision immunotherapies for cancer and autoimmune diseases.